Equity Purchase. Pursuant to the Stock Purchase Agreement, PathoGenesis shall purchase Two Million Five Hundred Thousand Dollars ($2,500,000) of Series E Preferred Stock of AeroGen, at a purchase price of $2.60 per share.
Appears in 4 contracts
Samples: Product Development and Supply Agreement (Aerogen Inc), Product Development and Supply Agreement (Aerogen Inc), Product Development and Supply Agreement (Aerogen Inc)